SCHEMBL2768264

SCHEMBL2768264

COCCCNC(=O)N(S)c1noc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.42
HIF1A Q16665 5/20 0.41
HPGD P15428 3/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
APAF1 O14727 1/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
RECQL P46063 1/20 0.40
RAB9A P51151 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2769006 0.93 HPGD (0.43) SMN1; SMN2HIF1AHPGDALDH1A1LMNA
SCHEMBL2770586 0.84 MAOB (0.41) SMN1; SMN2HIF1AHPGDALDH1A1POLB
SCHEMBL2768569 0.82 HPGDS (0.38) SMN1; SMN2HPGDALDH1A1POLBTDP1
SCHEMBL2768303 0.82 RAB9A (0.41) SMN1; SMN2HIF1AHPGDLMNAKDM4E
SCHEMBL2768099 0.80 MAPT (0.47) SMN1; SMN2ALDH1A1MAPTNPC1RAB9A
SCHEMBL2770003 0.78 NPC1 (0.45) SMN1; SMN2HIF1AHPGDALDH1A1POLB
SCHEMBL2769784 0.78 NPC1 (0.38) SMN1; SMN2HIF1AHPGDLMNAKDM4E
SCHEMBL2768687 0.78 HIF1A (0.41) SMN1; SMN2HIF1ALMNAKDM4EMAPT
SCHEMBL2768895 0.76 MAPT (0.47) SMN1; SMN2HIF1ALMNAKMT2AMEN1
SCHEMBL2768827 0.74 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1POLBLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881967-B1 SUBSTITUTED BENZO(D)ISOXAZOL-3-YL AMINE COMPOUNDS AS ANALGESICS GRUENENTHAL GMBH (DE) 2010-04-28 EP claimed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US claimed
US-7696238-B2 Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics GRUENENTHAL GMBH (DE) 2010-04-13 US disclosed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics KCNQ1, KCNQ2, KCNQ3 SMN1; SMN2 1349/4885HIF1A 1664/4885HPGD 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.